Intellia Therapeutics, Inc. (NTLA) CEO John Leonard on Q2 2021 Results - Earnings Call TranscriptSeeking Alpha • 08/05/21
Intellia Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 08/05/21
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2021 Earnings and Company UpdatesGlobeNewsWire • 07/29/21
Intellia Therapeutics, Inc. (NTLA) Dips More Than Broader Markets: What You Should KnowZacks Investment Research • 07/27/21
After Game-Changing Clinical Trial Results, These 2 Cathie Wood Stocks Are ExplodingThe Motley Fool • 07/15/21
Intellia Therapeutics Announces Closing of $690 Million Public Offering of Common StockGlobeNewsWire • 07/02/21
The Top 7 Gene-Editing Stocks to Buy for the Biggest Scientific Breakthrough of the CenturyInvestorPlace • 07/01/21